-
Transcat acquires Essco Calibration Laboratory for $84 million
-
Transcat, Inc. (TRNS) Announces Retirement of Charles P. Hadeed from Board
-
Lake Street Capital Markets Starts Transcat Inc. (TRNS) at Buy, 'Growing Service Offering In Sticky Markets'
-
H.C. Wainwright Reiterates Buy Rating on Transcat Inc. (TRNS)
-
Northland Reiterates Market Perform Rating on Transcat Inc. (TRNS)
-
Transcat Inc. (TRNS) PT Raised to $105 at Craig-Hallum
-
Transcat Inc. (TRNS) PT Raised to $116 at H.C. Wainwright
-
Transcat, Inc. (TRNS) Tops Q4 EPS by 3c
-
Transcat Inc. (TRNS) PT Lowered to $94 at Craig-Hallum, 'We're Still Long-Term Believers'
-
Oppenheimer Downgrades Transcat Inc. (TRNS) to Perform
-
H.C. Wainwright Reiterates Buy Rating on Transcat Inc. (TRNS)
-
Transcat, Inc. (TRNS) Misses Q3 EPS by 2c, provides outlook
-
Transcat Inc. (TRNS) PT Raised to $125 at Craig-Hallum
-
Transcat (TRNS) Acquires Martin Calibration Inc.’s 7 Labs, Expanding Midwest Service Presence, Including Minneapolis
-
Transcat Inc. (TRNS) PT Lowered to $113 at Craig-Hallum
-
H.C. Wainwright Reiterates Buy Rating on Transcat Inc. (TRNS)
-
Transcat, Inc. (TRNS) Misses Q2 EPS by 5c
-
Transcat, Inc. (TRNS) Tops Q1 EPS by 5c, provides outlook
-
Terns Pharmaceuticals (TERN): Kenneth Griffin Reports 5.3% Stake

